Sign in
NLSP Stock Price, Chart, Stats & News
NLS Pharmaceutics AG
Save
NLS Pharmaceutics AG (NLSP) does not currently pay a dividend.
919,601
Market cap
–
Current P/E
–
Forward P/E
NLSP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -49.93% |
ROE | -100.99% |
D/E | – |
Interest coverage ratio | -64.74x |
NLSP valuation
P/E | – |
P/S | – |
P/B | 0.40x |
P/CF | -0.24x |
P/FCF | -0.19x |
P/OCF | -0.24x |
PEG | 0.01x |
EV multiple | -1.05x |
About
NLS Pharmaceutics AG is a biopharmaceutical firm dedicated to researching and creating treatments for intricate and uncommon conditions affecting the central nervous system. Its primary focus includes advancing medications for narcolepsy, idiopathic hypersomnia, and various other unusual sleep conditions, alongside neurodevelopmental challenges like attention deficit hyperactivity disorder (ADHD). Key experimental compounds in its pipeline are Quilience, designed to address excessive daytime sleepiness and cataplexy, and Nolazol, which targets ADHD.
Similar securities
Based on sector and market capitalization
Report issue